# Starling Oncology Inc. (STLN)

Source: https://www.quantisnow.com/company/STLN
Generated: 2026-11-13T06:52:06.853Z

- Ticker: STLN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Nursing Services
- IPO year: 2020
- SEC CIK: 0001799191
- Website: https://www.theoncologyinstitute.com

## About

Founded in 2007, Starling Oncology, Inc. (Nasdaq: STLN) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Formerly known as The Oncology Institute, Starling Oncology offers cutting-edge, evidence-based cancer care to a population of approximately 2.2 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 400 employed and network clinicians and over 100 clinics and network locations of care across five states and growing, Starling Oncology is coordinating cancer care for the better.

## Latest STLN news and filings

- 2026-11-12 21:43 UTC [SEC Form 8-K] [Amendment: Starling Oncology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-starling-oncology-inc-filed-sec-form-8-k-regulation-fd-6788583)
- 2026-11-12 13:15 UTC [SEC Form 4] [Large owner Chernett Jorey acquired $1,113 worth of Call Option (1,391 units at $0.80) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-chernett-jorey-acquired-1113-worth-of-call-option-6786574)
- 2026-11-12 13:03 UTC [SEC Form 8-K] [Starling Oncology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/starling-oncology-inc-filed-sec-form-8-k-regulation-fd-disclosure-6786517)
- 2026-11-10 23:33 UTC [Insider Buy] [Large owner Chernett Jorey sold $11,375,733 worth of shares (2,851,061 units at $3.99) and bought $176,273 worth of shares (48,294 units at $3.65), decreasing direct ownership by 26% to 7,858,091 units (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-chernett-jorey-sold-11375733-worth-of-shares-2851061-6784888)
- 2026-11-05 23:03 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Starling Oncology Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-starling-oncology-inc-6777697)
- 2026-11-05 21:57 UTC [SEC Form 8-K] [Starling Oncology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/starling-oncology-inc-filed-sec-form-8-k-results-of-operations-6777191)
- 2026-11-05 21:06 UTC [Earnings] [Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance](https://www.quantisnow.com/insight/starling-oncology-reports-third-quarter-2026-financial-results-and-updates-6776261)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/STLN
- Earnings history: https://www.quantisnow.com/earnings/STLN
- Dividend history: https://www.quantisnow.com/dividends/STLN
- Insider transactions: https://www.quantisnow.com/insiders/STLN
- Options chain: https://www.quantisnow.com/options/STLN
- SEC 8-K filings only: https://www.quantisnow.com/company/STLN/8-k
- RSS and alerts for STLN: https://www.quantisnow.com/docs/rss-feeds.md